Rockland Trust’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$322K Buy
3,555
+63
+2% +$5.28K 0.01% 268
2026
Q1
$280K Sell
3,492
-354
-9% -$29.2K 0.01% 281
2025
Q4
$328K Buy
3,846
+360
+10% +$29.5K 0.01% 255
2025
Q3
$271K Sell
3,486
-11
-0.3% -$859 0.01% 269
2025
Q2
$274K Sell
3,497
-658
-16% -$49.1K 0.01% 224
2025
Q1
$301K Sell
4,155
-198
-5% -$14.2K 0.02% 221
2024
Q4
$322K Buy
4,353
+334
+8% +$23.4K 0.02% 226
2024
Q3
$265K Hold
4,019
0.01% 245
2024
Q2
$371K Sell
4,019
-1,162
-22% -$103K 0.02% 228
2024
Q1
$495K Sell
5,181
-4,208
-45% -$353K 0.03% 203
2023
Q4
$716K Buy
9,389
+1,160
+14% +$80.7K 0.04% 170
2023
Q3
$570K Sell
8,229
-390
-5% -$31.3K 0.03% 186
2023
Q2
$813K Sell
8,619
-20
-0.2% -$1.74K 0.05% 160
2023
Q1
$715K Buy
8,639
+122
+1% +$9.59K 0.04% 166
2022
Q4
$635K Buy
8,517
+2,040
+31% +$157K 0.04% 184
2022
Q3
$535K Sell
6,477
-901
-12% -$86.7K 0.04% 174
2022
Q2
$702K Buy
7,378
+942
+15% +$97.5K 0.05% 155
2022
Q1
$758K Sell
6,436
-501
-7% -$56.2K 0.05% 164
2021
Q4
$899K Buy
6,937
+5,097
+277% +$595K 0.06% 157
2021
Q3
$208K Buy
+1,840
New +$210K 0.01% 274

Other funds holding EW

Rockland Trust's EW Position: Q2 2026 in Review

Rockland Trust increased its Edwards Lifesciences (EW) stake by 1.8% in Q2 2026, buying an estimated $5.28K and bringing the position to 3,555 shares worth $322K. The position accounts for 0.01% of the portfolio, ranked #268.

Rockland Trust first reported a position in EW in Q3 2021 and has held it in 20 quarters since. The position peaked at $899K in Q4 2021. 597 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Rockland Trust held 3,555 shares of Edwards Lifesciences worth $322K as of Q2 2026.
  • Rockland Trust bought 63 Edwards Lifesciences shares in Q2 2026, an estimated $5.28K.
  • Edwards Lifesciences made up 0.01% of Rockland Trust's portfolio in Q2 2026, its #268 holding.
  • Rockland Trust first reported a position in Edwards Lifesciences in Q3 2021 and has held it in 20 quarters since.
  • Rockland Trust's Edwards Lifesciences position peaked at $899K in Q4 2021.
  • 597 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Rockland Trust's 13F filing for Q2 2026, filed 8 Jul 2026.